C
linical nutrition education is a key component of medical nutrition therapy and diabetes self-management practices (1) . Several research studies have documented the effectiveness of clinical nutrition education when delivered as a component of a comprehensive plan of care by a multidisciplinary team, and current expert consensus suggests that the primary instructors on the diabetes team should have specialized diabetes and educational training at or beyond basic academic preparation (2) (3) (4) (5) . This consensus opinion has been used to shape policy for reimbursement of Diabetes Self-Management Education and Medical Nutrition Therapy programs (6) , although empiric evidence for the effectiveness of clinical nutrition education in a national health care system and the role of discipline of the educator has yet to be documented.
We used the Indian Health Service (IHS) Diabetes Care and Outcomes Audit to assess the effectiveness of clinical nutrition education in reducing HbA 1c when delivered as a component of multidisciplinary diabetes care in this large national health care organization and to test the relative effectiveness of clinical nutrition education when it was delivered by a registered dietitian (RD) compared with an educator from another discipline (non-RD).
RESEARCH DESIGN AND METHODS

Data collection
We examined clinical care data collected by the IHS Diabetes Care and Outcomes Audit of medical records performed at 218 different facilities during 2001. Methods for the audit have been described previously (7) (8) (9) . Briefly, IHS and tribal clinic facilities are encouraged to maintain diabetes registries of all individuals with diabetes. Regional diabetes coordinators and professional staff members, trained by the coordinators, perform an audit of clinical care on a randomly selected sample of records of patients on the local registries. Data from the medical record are abstracted using standardized protocols and data collection forms. In addition to manual record abstraction, in 2001, 11% of sites collected patient encounter information using an electronic audit application that retrieved data from clinical and administrative databases of the Resource and Patient Management System (RPMS). Data are then entered or imported into a generalpurpose microcomputer-based software program. Although validation studies of the audit have not been conducted to as-sess interobserver variation on documentation of education between facilities, we did find a moderate agreement between manual chart reviewers and electronically created audits at one large facility with respect to the presence or absence of documentation of clinical nutrition education (observed agreement 0.73, 0.36). 
Glycemic control
Clinical nutrition education
Clinical nutrition education was defined as documentation in the medical record of diet instruction. The audit identifies whether the education was provided by an RD, a non-RD, by both an RD and a non-RD, or none. The timing of the education relative to the interval HbA 1c measurements was not documented in the audit; however, the education and the HbA 1c measurements must have occurred within the year before the audit.
The IHS follows the Commission on Accreditation for Dietetics Education of the American Dietetic Association in identifying an RD as an individual who has completed the minimum of a baccalaureate degree granted by a U.S. regionally accredited college or university or foreign equivalent, has met current minimum academic requirements and completed preprofessional experience, has successfully completed the Registration Examination for Dietitians, and has accrued 75 h of approved continuing professional education every 5 years (10). non-RDs could include, but would not be limited to, physicians, physician assistants, nurse practitioners, nurses, or health educators. In addition to the professional training and accreditation of the educator, clinical nutrition education instruction by an RD typically differs from that of a non-RD. Clinical nutrition education encounters by an RD are generally longer in duration and involve a nutrition assessment, goal setting, intervention, and plans for follow-up. Clinical nutrition education instruction by a non-RD provider typically comes in response to a patient request or upon identification of a clinical problem during the course of delivering medical care. non-RD instructions on clinical nutrition are often brief and focused on the transfer of generally available verbal or written information.
Covariates
In addition to HbA 1c values and clinical nutrition education documentation and clinical nutrition educator discipline, additional demographic, clinical, and standard of care variables were collected in the audit and include facility, sex, age, height, weight, duration of diabetes, diabetes classification, type of treatment, diet instruction, and urinary protein assessments. Age was calculated at the date of audit. BMI was calculated from recorded height and weight [(703 ϫ weight in pounds)/(height in inches ϫ height in inches)]. Duration of diabetes was recorded as time since diagnosis in years. Type of treatment was recorded as diet alone (no medication), oral agent (used singly or in combination with other oral agents), or insulin. For purposes of analysis, when oral agents were used in combination with insulin, the patient was included with the insulin treatment group. Proteinuria was defined as having 1ϩ (30 mg/dl) or greater protein on a urine dipstick in the past year.
Data analyses
The primary study end point, the difference between the two most recent HbA 1c values, was conducted for all people with two measured HbA 1c values. To test whether the differences in HbA 1c level varied by diet instruction and to adjust for covariates that might affect the relationship, we used ANCOVA (11) . The chosen covariates for adjustment included age, sex, BMI, duration of diabetes, type of treatment, and facility. For this report, we restricted our analysis to patients older than 18 years of age who did not have proteinuria. Effect modifiers were assessed using significance tests for interaction terms or by fitting nested models. All statistical analyses were performed using SAS statistical software (SAS Institute, Cary, NC) (12). Table 1 . Consistent with sex differences in the prevalence of diabetes in American Indian/Alaska Natives, more women than men were included in the sample. The mean age of the patients was 55.2 years, mean duration of diabetes was 7.9 years, and mean BMI was 33.7 kg/m 2 . The mean HbA 1c level was 8.0%. Most patients were treated with oral agents (63%), followed by insulin (25.4%) and diet and exercise (11.6%). Patients excluded from the analysis because they had only one HbA 1c level were similar to those included, except that they had a shorter mean duration (6.3 years), a greater proportion of treatment by diet and exercise oral agents (21.4%), and smaller proportion treated with insulin (18.4%).
RESULTS
We found that, overall, clinical nutrition education was associated with improving HbA 1c values during 2001 (Table  2) . After adjustment for age, sex, type of treatment, duration of diabetes, BMI, initial HbA 1c level, and clinical facility, there was statistically significant improvement in HbA 1c values among patients receiving clinical nutrition education compared with those who did not (Ϫ0.09 vs. 0.06, respectively). In addition, there was a statistically significant improvement in HbA 1c value among those receiving clini-cal nutrition education from an RD and both an RD and a non-RD (Ϫ0.26 vs. Ϫ0.32, respectively; P Ͻ 0.0001). The difference between RD instruction and both RD and non-RD instruction was not statistically significant (P Ͼ 0.05). Among those receiving clinical nutrition education from only non-RD educators, HbA 1c values improved (Ϫ0.19); however, the change was not statistically different from those having no documentation of education (Ϫ0.10).
When analyses were stratified by type of treatment, all clinical nutrition education groups had improvements in HbA 1c levels compared with those receiving no education among patients treated with diet and exercise alone or oral agents (Table 3). This difference was statistically significant for those receiving oral therapies (P Ͻ 0.0001). Among those receiving diet therapy, the mean decrease in HbA 1c level was Ϫ0.23 for RD and Ϫ0.18 for both RD and non-RD. The mean decrease in HbA 1c level was Ϫ0.10 for diet instruction by a non-RD and was not statistically significant (P ϭ 0.09). For those patients receiving oral agent therapies, the mean decrease in HbA 1c value was Ϫ0.23 for RD, Ϫ0.33 for both RD and non-RD, and Ϫ0.12 for non-RD. The improvement in HbA 1c value among those receiving clinical nutrition education from an RD and from both RD and non-RD was statistically significantly different from those who did not receive clinical nutrition education. In addition, the improvement in HbA 1c value for those receiving clinical nutrition education from both an RD and a non-RD was statistically significantly different from those receiving clinical nutrition education from another educator. The difference between RD instruction and both RD and non-RD instruction was not statistically significant (P Ͼ 0.05). In contrast, none of the clinical nutrition education groups showed improvements in HbA 1c values among patients receiving insulin therapy.
CONCLUSIONS -We found that documentation of clinical nutrition education provided in the IHS was associated with improvements in HbA 1c values. In this setting, in which care is delivered by a multidisciplinary team, HbA 1c values improved when the education team included an RD but not when clinical nutrition education was provided by a non-RD. This observation provides evidence that the effectiveness of clinical nutrition education found in clinical trials is translatable into routine clinical practice in a large national health care program. Our observation also uniquely confirms the relative importance of the RD compared with the non-RD in achieving desired glycemic control outcomes from the clinical nutrition education process.
There is reason to believe that the observed effect of clinical nutrition education on the difference between the two most recent HbA 1c values in this study is clinically and statistically significant. The IHS Standards of Care for Diabetes Mellitus recommends measurement of HbA 1c quarterly and clinical nutrition education annually. For the purpose of analysis, we have assumed that clinical nutrition education occurred before or during the measurement interval. We have estimated, from a large sample of patients at a single institution, that the measurement interval was ϳ132 days and was comparable between the education groups. If the differences observed over this 132-day period were projected over a year, this would result in an ϳ0.27-unit decrease in HbA 1c for patients receiving clinical nutrition education compared with a 0.18-unit increase in HbA 1c for individuals not receiving clinical nutrition education. The comparable improvement in HbA 1c value when an RD was a part of the instruction team was of a greater magnitude. If projected over a year, RD instruction would result in a 0.78-unit decrease and instruc- tion by both an RD and a non-RD would result in a 0.96-unit decrease. This magnitude is comparable to the decrease in HbA 1c seen in clinical trials of education in diabetes and would be comparable to some medication interventions (5) . Because this data comes from audits of actual clinical practice, the quality of documentation, the timing and intensity of the education process itself, and the interval of HbA 1c measurement are likely much more variable than we have assumed. This variability would likely bias against the finding of an association between the education groups. Therefore, we believe that the differences observed may be conservative estimates of overall magnitude and an underestimate of the relative effect of RDs compared with nonRDs. Interestingly, we did not see an improvement in the subset of patients treated with insulin. The reasons for this are not known. However, we suspect that insulin therapy is a marker for more advanced diabetes where, because of progressive metabolic deterioration and ␤-cell dysfunction, even appropriate dietary therapies would be less effective than medication therapies in achieving glycemic control (13) . In support of this hypothesis, when we looked at a different set of patients with proteinuria, another marker of more advanced diabetes, there were no differences in HbA 1c values among any of the clinical nutrition education groups (data not shown). We do not suggest that clinical nutrition education is not valuable in patients with more advanced diabetes but that the effect on glycemic outcomes is not or is at least less demonstrable.
Although our data are consistent with the possibility that dietary education by an RD results in improved glycemic control outcomes in patients with diabetes, this was an observational study, and we cannot assign causality to the associations identified. Patient characteristics and behaviors may have significantly influenced whether an RD was involved in the educational process. Such patient-specific differences may have influenced changes in HbA 1c value during the study period. We did attempt to account for some patient level differences by adjusting the HbA 1c difference for age, sex, type of treatment, duration of diabetes, BMI, and initial HbA 1c level. Facility level differences may also have played a role. For example, facilities that have RDs as members of the education team could potentially differ in a variety of ways from facilities without RDs, which in turn may have influenced the patient outcomes. Therefore, we sought to adjust for such differences by including a variable for the facility in our models. Finally, we cannot determine what quantitative or qualitative differences in the educational process between RD and non-RD clinical nutrition educators might reasonably be associated with the observed outcomes. Further research and data gathering will be needed to better understand these associations.
In summary, documentation of clinical nutrition education as delivered in this large health care organization is associated with favorable trends in glycemic control during a 1-year audit period. Our data support the concept that clinical nutrition education should be delivered by an RD or a team that includes an RD to be effective in achieving better glycemic control and reducing the risk for future complications. 
